
Emily M. Le
Examiner (ID: 5908)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1734, 1793 |
| Total Applications | 433 |
| Issued Applications | 74 |
| Pending Applications | 96 |
| Abandoned Applications | 266 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6804624
[patent_doc_number] => 20030232018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Stabilized formulations of adenovirus'
[patent_app_type] => new
[patent_app_number] => 10/342344
[patent_app_country] => US
[patent_app_date] => 2003-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6376
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10342344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/342344 | Stabilized formulations of adenovirus | Jan 14, 2003 | Abandoned |
Array
(
[id] => 662420
[patent_doc_number] => 07101676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-05
[patent_title] => 'Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA'
[patent_app_type] => utility
[patent_app_number] => 10/339217
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16163
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101676.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339217 | Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA | Jan 8, 2003 | Issued |
Array
(
[id] => 6643613
[patent_doc_number] => 20030104067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Method of obtaining cellular immune responses from proteins'
[patent_app_type] => new
[patent_app_number] => 10/340034
[patent_app_country] => US
[patent_app_date] => 2003-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11125
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104067.pdf
[firstpage_image] =>[orig_patent_app_number] => 10340034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/340034 | Method of obtaining cellular immune responses from proteins | Jan 7, 2003 | Issued |
Array
(
[id] => 879340
[patent_doc_number] => 07354711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Methods for inhibiting immunostimulatory DNA associated responses'
[patent_app_type] => utility
[patent_app_number] => 10/336635
[patent_app_country] => US
[patent_app_date] => 2003-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 9910
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/354/07354711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10336635
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/336635 | Methods for inhibiting immunostimulatory DNA associated responses | Jan 2, 2003 | Issued |
Array
(
[id] => 32601
[patent_doc_number] => 07785610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Chimeric immunomodulatory compounds and methods of using the same—III'
[patent_app_type] => utility
[patent_app_number] => 10/328578
[patent_app_country] => US
[patent_app_date] => 2002-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 26
[patent_no_of_words] => 66261
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785610.pdf
[firstpage_image] =>[orig_patent_app_number] => 10328578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/328578 | Chimeric immunomodulatory compounds and methods of using the same—III | Dec 22, 2002 | Issued |
Array
(
[id] => 1071764
[patent_doc_number] => 06841346
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-11
[patent_title] => 'Methods for detecting bacteriophage MS2'
[patent_app_type] => utility
[patent_app_number] => 10/328226
[patent_app_country] => US
[patent_app_date] => 2002-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7309
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10328226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/328226 | Methods for detecting bacteriophage MS2 | Dec 22, 2002 | Issued |
Array
(
[id] => 1076716
[patent_doc_number] => 07615227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'Use of CpG oligodeoxynucleotides to induce angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/499597
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13027
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615227.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499597 | Use of CpG oligodeoxynucleotides to induce angiogenesis | Dec 18, 2002 | Issued |
Array
(
[id] => 6855701
[patent_doc_number] => 20030129202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/169668
[patent_app_country] => US
[patent_app_date] => 2002-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17406
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129202.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169668
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169668 | Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof | Dec 15, 2002 | Abandoned |
Array
(
[id] => 7394290
[patent_doc_number] => 20040038373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder'
[patent_app_type] => new
[patent_app_number] => 10/314869
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12768
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314869
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314869 | Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder | Dec 8, 2002 | Abandoned |
Array
(
[id] => 6865553
[patent_doc_number] => 20030191079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Methods for treating and preventing infectious disease'
[patent_app_type] => new
[patent_app_number] => 10/306522
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26950
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306522 | Methods for treating and preventing infectious disease | Nov 26, 2002 | Issued |
Array
(
[id] => 6822116
[patent_doc_number] => 20030220277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Methylation of plasmid vectors'
[patent_app_type] => new
[patent_app_number] => 10/291041
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15135
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220277.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291041 | Methylation of plasmid vectors | Nov 7, 2002 | Abandoned |
Array
(
[id] => 6678139
[patent_doc_number] => 20030228279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Compositions and methods for viral delivery'
[patent_app_type] => new
[patent_app_number] => 10/283484
[patent_app_country] => US
[patent_app_date] => 2002-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25610
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228279.pdf
[firstpage_image] =>[orig_patent_app_number] => 10283484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/283484 | Compositions and methods for viral delivery | Oct 28, 2002 | Abandoned |
Array
(
[id] => 6649238
[patent_doc_number] => 20030104613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Method for producing adherent animal cells'
[patent_app_type] => new
[patent_app_number] => 10/148514
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9446
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104613.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148514 | Method for producing adherent animal cells | Oct 8, 2002 | Abandoned |
| 09/958713 | Oligodeoxynucleotide and its use to induce an immune response | Oct 6, 2002 | Abandoned |
Array
(
[id] => 6740246
[patent_doc_number] => 20030157615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/145128
[patent_app_country] => US
[patent_app_date] => 2002-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192233
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157615.pdf
[firstpage_image] =>[orig_patent_app_number] => 10145128
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/145128 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 30, 2002 | Abandoned |
| 10/129031 | Recombinant therapeutic fusion proteins | Sep 30, 2002 | Abandoned |
Array
(
[id] => 4791713
[patent_doc_number] => 20080292686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/491482
[patent_app_country] => US
[patent_app_date] => 2002-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8140
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292686.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491482 | Vaccine | Sep 29, 2002 | Abandoned |
Array
(
[id] => 6705842
[patent_doc_number] => 20030152576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Interaction between cd14 and hbv components'
[patent_app_type] => new
[patent_app_number] => 10/168032
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 16490
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20030152576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168032 | Interaction between cd14 and hbv components | Sep 26, 2002 | Abandoned |
Array
(
[id] => 7269451
[patent_doc_number] => 20040057969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Compositions containing stabilized hepatitis antigen and methods of their use'
[patent_app_type] => new
[patent_app_number] => 10/251167
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 20258
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20040057969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251167 | Compositions containing stabilized hepatitis antigen and methods of their use | Sep 19, 2002 | Abandoned |
Array
(
[id] => 6668880
[patent_doc_number] => 20030113864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/247058
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45008
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247058 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 17, 2002 | Abandoned |